Literature DB >> 28901578

Irritable bowel syndrome in Asia: Pathogenesis, natural history, epidemiology, and management.

Kok-Ann Gwee1, Uday Chand Ghoshal2, Minhu Chen3.   

Abstract

Historically, the epidemiology of gastrointestinal diseases in Asia was different from that in Western countries. Early studies suggested a low prevalence of irritable bowel syndrome (IBS) in Asia. As the diagnosis of IBS is symptom-based and as symptom perception, expression, and interpretation are influenced by sociocultural perspectives including language, the presentation of IBS is expected to vary in different communities. Furthermore, the pathogenesis is multifactorial with psychosocial (stress, illness, behavior, and diet) and biological (infection, gut microbiota, and immune activation) variables interacting, and so, the present study can anticipate that the development of IBS will vary in different environments. In recognition of this aspect of functional gastrointestinal disorders, the recently published Rome IV documents have provided greater focus on cross-cultural factors. In this review, the present study seeks to highlight Asian perspectives by identifying historical trends and recent publications from the region and comparing these with the observations from Western societies.
© 2017 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  Asia; Rome criteria; abdominal pain; antispasmodics; bloating; cross-cultural research; diet; irritable bowel syndrome

Mesh:

Year:  2018        PMID: 28901578     DOI: 10.1111/jgh.13987

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  25 in total

1.  Significant Differences in Gut Microbiota Between Irritable Bowel Syndrome with Diarrhea and Healthy Controls in Southwest China.

Authors:  Chengjiao Yao; Yilin Li; Lihong Luo; Fengjiao Xie; Qin Xiong; Tinglin Li; Chunrong Yang; Pei-Min Feng
Journal:  Dig Dis Sci       Date:  2022-05-03       Impact factor: 3.199

2.  Prevalence and Associated Risk Factors of Irritable Bowel Syndrome Among Female Secondary School students in Ar Rass City, Qassim Region.

Authors:  Wjdan Alharbi; Saulat Jahan
Journal:  Health Psychol Res       Date:  2022-05-30

Review 3.  Global burden of irritable bowel syndrome: trends, predictions and risk factors.

Authors:  Christopher J Black; Alexander C Ford
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-04-15       Impact factor: 46.802

Review 4.  Low fermentable oligosaccharides, disaccharides, monosaccharides, and polypols diet and irritable bowel syndrome in Asia.

Authors:  Yihe Zhang; Zheng Feei Ma; Hongxia Zhang; Binyu Pan; Yeshan Li; Hazreen A Majid; Yeong Yeh Lee
Journal:  JGH Open       Date:  2018-12-28

Review 5.  Second Asian Consensus on Irritable Bowel Syndrome.

Authors:  Kok Ann Gwee; Sutep Gonlachanvit; Uday C Ghoshal; Andrew S B Chua; Hiroto Miwa; Justin Wu; Young-Tae Bak; Oh Young Lee; Ching-Liang Lu; Hyojin Park; Minhu Chen; Ari F Syam; Philip Abraham; Jose Sollano; Chi-Sen Chang; Hidekazu Suzuki; Xiucai Fang; Shin Fukudo; Myung-Gyu Choi; Xiaohua Hou; Michio Hongo
Journal:  J Neurogastroenterol Motil       Date:  2019-07-01       Impact factor: 4.924

6.  Efficacy and safety of lactulose for the treatment of irritable bowel syndrome.

Authors:  Hong-Bin Chen; Xiao-Ying Su
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

Review 7.  Effectiveness of vitamin D for irritable bowel syndrome: A protocol for a systematic review of randomized controlled trial.

Authors:  Sheng-Mei Shi; Yan-Li Wen; Hai-Bin Hou; Hai-Xia Liu
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.889

8.  Depression Promotes the Onset of Irritable Bowel Syndrome through Unique Dysbiosis in Rats.

Authors:  Takeshi Takajo; Kengo Tomita; Hanae Tsuchihashi; Shingo Enomoto; Masaaki Tanichi; Hiroyuki Toda; Yoshikiyo Okada; Hirotaka Furuhashi; Nao Sugihara; Akinori Wada; Kazuki Horiuchi; Kenichi Inaba; Yoshinori Hanawa; Naoki Shibuya; Kazuhiko Shirakabe; Masaaki Higashiyama; Chie Kurihara; Chikako Watanabe; Shunsuke Komoto; Shigeaki Nagao; Katsunori Kimura; Soichiro Miura; Kunio Shimizu; Ryota Hokari
Journal:  Gut Liver       Date:  2019-05-15       Impact factor: 4.519

9.  Short-course Rifaximin therapy efficacy and lactulose hydrogen breath test in Chinese patients with diarrhea-predominant irritable bowel syndrome.

Authors:  Xiaojun Zhuang; Zhenyi Tian; Mei Luo; Lishou Xiong
Journal:  BMC Gastroenterol       Date:  2020-06-12       Impact factor: 3.067

10.  Upregulation of the high-affinity choline transporter in colon relieves stress-induced hyperalgesia.

Authors:  Meng-Juan Lin; Bao-Ping Yu
Journal:  J Pain Res       Date:  2018-09-21       Impact factor: 3.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.